Lead research linking focused ultrasound, synthetic biology and cancer immunotherapy in Nate Yoon’s RPBS Lab. Projects include ultrasound-responsive gene circuits, immune-cell mechanotransduction and acoustic tools for imaging and therapy. Mentor students and develop an independent research trajectory in an interdisciplinary engineering environment. The expected start is 15 January 2027. Applications received by 1 October 2026 receive full consideration; the employer explicitly continues accepting applications until the position is filled.
Genetic-based brain machine interfaces for visual restoration
Serge Picaud · Institute Vision Paris
Wed, Apr 13, 2022 · 13:00 UTC
Visual restoration is certainly the greatest challenge for brain-machine interfaces with the high pixel number and high refreshing rate. In the recent year, we brought retinal prostheses and optogenetic therapy up to successful clinical trials. Concerning visual restoration at the cortical level, prostheses have shown efficacy for limited periods of time and limited pixel numbers. We are investigating the potential of sonogenetics to develop a non-contact brain machine interface allowing long-lasting activation of the visual cortex. The presentation will introduce our genetic-based brain machi
New Frontiers in Understanding and Treating Migraine Headaches
Lars Edvinsson · Lund University, Sweden & University of Copenhagen, Denmark
Thu, May 27, 2021 · 16:00 UTC
In this presentation I will describe how the CGRP project started and culminated in the development of gepants and mAbs for successful therapy. The outstanding question regarding the preponderance of female migraineurs also remains. I will present views on the reason behind this and suggest that understanding the hormonal influence will pave the way to alleviating hormone related migraine.
Affordable Robots/Computer Systems to Identify, Assess, and Treat Impairment After Brain Injury
Michelle Johnson · University of Pennsylvania, Department of Physical Medicine and Rehabilitation and Department of BioEngineering
Wed, Oct 7, 2020 · 17:30 UTC
Non-traumatic brain injury due to stroke, cerebral palsy and HIV often result in serious long-term disability worldwide, affecting more than 150 million persons globally; with the majority of persons living in low and middle income countries. These diseases often result in varying levels of motor and cognitive impairment due to brain injury which then affects the person’s ability to complete activities of daily living and fully participate in society. Increasingly advanced technologies are being used to support identification, diagnosis, assessment, and therapy for patients with brain injury.